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Abstract 
Purpose: To formulate and evaluate floating microparticulate oral diltiazem delivery system for possible 
delivery to the heart. 
Method: Floating microspheres were prepared using cellulose acetate and Eudragit RS100 polymers 
by emulsion solvent evaporation technique. The dried floating microspheres were evaluated for 
micromeritic properties (flow properties, density, particle size determination) scanning as well as by 
electron microscopy, and in vitro floatability and drug release studies.  
Results: The microspheres showed good buoyancy, good flow properties (angle of repose ranging from 
24.29 to 29.02 º), particle size (262.09 to 409.60 µm) and good drug loading (74.29 to 92.09 %). The 
microspheres were porous, hollow and spherical. All the formulations showed good in vitro controlled 
drug release in the range of 77.62 ± 2.12 to 97.50 ± 1.04 % at the end of 12 h. Drug release was 
diffusion-controlled and followed zero order kinetics.  
Conclusion: Microparticulate floating (gastroretentive) oral drug delivery system of diltiazem prepared 
using cellulose acetate and Eudragit R5100 may be an effective alternative to conventional oral tablets 
for cardiac drug delivery.  
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INTRODUCTION 
 
Most drugs are given by oral route as this is the 
most acceptable, convenient and least invasive 
approach for getting systemic delivery of 
significant therapeutic levels of drug. Drugs used 
in the management of cardiac diseases are to be 
taken for longer periods of time for maintaining 
blood pressure, heart beat or overall cardiac 
health. Unlike other routes the oral route is the 
most preferred route of drug administration. It is 
also the preferred route to deliver sustained and 
controlled delivery of drugs [1].  
 
However, there are many constraints in 
designing oral controlled-release drug delivery 
systems. These include varying pH changes and 
gastric emptying time, variation in pH across the 
regions of the gastrointestinal tract (GIT) and 
varying absorption windows available for different 
drugs. Various approaches have been 
investigated for localizing the drug to the upper 
part of the GIT. These include development of 
gastroretentive drug delivery systems through 
utilizing the approaches based on buoyancy, 
mucoadhesion, low density, etc [2,3]. 
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 An ideal gastroretentive drug delivery system 
(GRDDS) localizes the drug in the upper 
segments of the GIT so that the drug gets 
maximum chance to get absorbed from the site 
where it is optimally absorbed [4-7]. 
 
Diltiazem hydrochloride, an L type calcium 
channel blocker, is a widely used cardiovascular 
drug, for the treatment of angina, essential 
hypertension and atrial flutter. When 
administered orally, frequent dosing is needed 
due to its short biological half-life (t1/2, 4 h) 
[11,12]. Diltiazem undergoes high hepatic first 
pass metabolism, and thus, bioavailability is 
reduced to only 40 %. Moreover, diltiazem shows 
absorption window phenomenon because it is 
preferentially absorbed from the upper GIT.  
   
Therefore the present investigation aimed to 
formulate and evaluate gastroretentive buoyant 
microspheres of diltiazem hydrochloride that 
would localize the delivery system to the upper 
GIT from where it would be expected to slowly 
and continuously release the drug in a controlled 
manner leading to improved bioavailability [13-
15].  
 
EXPERIMENTAL  
 
Diltiazem hydrochloride (DTH), Polyvinyl alcohol 
(PVA), Tween 80 and Cellulose Acetate were 
procured from Sigma Aldrich USA. All other 
reagents used were of analytical grade. 
 
Preparation of diltiazem hydrochloride micro 
particles 
 
Microparticles loaded with DTH were prepared 
using an oil-in-water (O/W) emulsification solvent 
evaporation method [16]. Six formulations were 
prepared using different polymers- Cellulose 
acetate and Eudragit RS100 (Table 1). 
 
Drug and polymer in different proportions 1:1, 
1:2, 1:4, were dissolved in the mixture of solvent 
system (dichloromethane, ethanol and isopropyl 
alcohol) or (ethyl acetate and acetone). The 
solution obtained was poured slowly into the 
aqueous phase consisting of 150 mL of 0.1 M 
hydrochloric acid solution containing polyvinyl 
alcohol. The emulsion was continuously stirred at 
a speed of 800 rpm using mechanical stirrer at 
room temperature for 2 h. The microspheres 
were collected by decantation, while the non-
floating microspheres were discarded along with 
any polymer precipitates. The microspheres were 
dried in an oven at 50 oC for 2 h, weighed and 
then stored in a desiccator at room temperature 
till further use.  
 
Scanning electron microscopy 
 
To detect the surface morphology of the 
microspheres, SEM of the floating microspheres 
was performed using Scanning Electron 
Microscope (Jeol of Japan Model No. 5600).  
 
Evaluation of micromeritic properties of 
floating microspheres 
 
The microspheres were characterized for their 
micromeritic properties, such as particle size (by 
optical microscopy), true density (by liquid 
displacement method) and flow properties (angle 
of repose) as reported in various previous 
studies [17-19]. 
 
Drug loading 
 
Drug loading (L) was determined by the method 
reported by Semalty et al as in Eq 1 [17-19]. 
 
L = (Qm/Wm)100 ………………………… (1) 
 
where Wm is the weight of microspheres and Qm 
is the quantity of drug present in Wm of 
microspheres. 
 
Table 1: Composition of the formulations 
 
Ingredient Formulation* 
F1 F2 F3 F4 F5 F6 
Diltiazem 
hydrochloride 
1 1 1 1 1 1 
Cellulose acetate 1 2 4 - - - 
Eudragit RS100 - - - 1 2 4 
Polyvinyl alcohol (% 
w/v) 
0.05 0.05 0.05 0.5 0.5 0.5 
*For formulations F1, F2 and F3, the solvent system was ethyl acetate: Acetone (1:1) while for formulations F4, 
F5 and F6, the solvent system was dichloromethane: ethanol: isopropyl alcohol (1:2:1); ratio are % w/w of 
polymers; batch size was 15 gm 
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In vitro floatability studies  
 
In vitro floatability studies on floating 
microspheres were carried out using USP 
apparatus II as reported earlier [17,20]. The 
buoyancy was calculated as in Eq 2.  
 
Buoyancy (%) = Wf /(Wf + Ws)100 ……..(2)  
 
where Wf and Ws are weights of the floating and 
the settled microspheres, respectively. 
 
In vitro drug release studies 
 
The release of DTH from the microspheres was 
studied in 900 ml of 0.1 N hydrochloric acid using 
USP XXIII method with six station dissolution test 
apparatus type 1 at 37 ± 0.5 o with a rotation 
speed of 100 rpm. For each formulation, a 
quantity of microspheres equivalent to 100 mg of 
diltiazem was filled in empty capsule shells (size 
00). One capsule was used in each test and 
placed in the basket. Samples of dissolution fluid 
were withdrawn at different intervals, filtered and 
diluted suitably and then analyzed 
spectrophotometrically (Double beam UV-Visible 
Spectrophotometer, Shimadzu, 1800, Japan) at 
236 nm.   
 
Statistical analysis 
 
The results were expressed as mean ± standard 
deviation (SD). Statistical analysis was carried 
out using analysis of variance (ANOVA) on 
GraphPad Prism© 4.0 (Graphpad Software Inc. 
San Diego, CA, USA). P < 0.05 was considered 
to be significant. 
 
RESULTS 
 
Microsphere morphology 
 
Scanning electron microscopy showed that the 
microspheres prepared using cellulose acetate 
and Eudragit RS100 had smooth spherical 
microspheres (Fig 1). Cellulose acetate 
microspheres exhibited a more uniform surface 
than those of Eudragit RS100 microspheres.  
 
 
 
 
 
Fig. 1: SEM photographs of floating microspheres of 
(a) Cellulose Acetate (b) Eudragit RS100 
 
Micromeritic properties  
 
Table 2 reports the results of flow properties of 
prepared floating microspheres like angle of 
repose, particle size and true density. 
 
The flow properties for the microparticles were 
good with angle of repose ranging from 24.29 º 
to 29.02 º. Density was in the range of 0.729 to 
0.820 g/cc3. Particle size was in the range of 
262.09 to 409.60 µm. Microspheres prepared 
with cellulose acetate (F1 - F3) were larger than 
those prepared with Eudragit R5100 
microspheres (F4 - F6). 
 
Drug loading 
 
The formulations showed excellent drug loading 
ranging from 74.29 to 92.09 % with higher 
loading found with cellulose acetate containing  
 
Table 2: Characteristics of floating microspheres 
 
Formulation Mean particle size (µm) 
True density 
(gm/cc3) Angle of repose 
Buoyancy 
12th h (%) 
Drug 
Loading (%) 
F1 341.30  1.082 0.780  0.035 24.29º  0.846 62.8  0.940 81.42  1.26 
F2 391.52  2.136 0.729  0.012 24.98º  0.009 79.8  1.252 88.90  1.49 
F3 409.60  3.543 0.809  0.020 23.80º  0.921 84.4  1.486 92.09  1.45 
F4 262.09  0.446 0.820  0.027 26.72º  0.072 60.9  1.280 74.29  1.69 
F5 274.80  2.227 0.744  0.042 29.02º 0.508 61.2  2.422 86.34  1.80 
F6 282.04  1.294 0.799  0.066 26.05º  1.080 68.6  2.005 84.90  1.89 
Results are presented as mean  standard deviation (n = 3) 
a 
b 
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Fig 2: In vitro drug release of gastroretentive microspheres of diltiazem hydrochloride in 0.1 M hydrochloric acid 
(pH 1.2). Key: (♦) F1, (□) F2, (▲) F3, (×) F4, (*) F5 and (●) F6 
 
microspheres (Table 2). Formulation F3 
containing cellulose acetate (with drug to 
polymer ratio of 1:4) showed maximum percent 
loading of drug (92.09 %). The rank order of 
Percent loading was found to be as follows - F3 
> F2 > F5 > F6 > F1 > F4. 
 
In vitro floatability  
 
The microspheres showed buoyancy ranging 
from 60.9 to 84.4 % at the end of 12 h (Table 2). 
Rank order of in vitro floatability was found to be 
as follows - F3 > F2 > F6 > F1 > F5 > F4. 
 
In-vitro release 
 
In vitro release studies of all the formulations 
were found to be good for a 12 h dissolution 
study (Fig 2). 
 
Change in polymer and drug to polymer ratio 
showed the change in drug release. At the end of 
12 h, release was 97.50, 94.44, 91.52 , 88.24, 
84.84 and 77.62 %  for formulations F1, F2, F3, 
F4, F5 and F6 respectively (Fig 2). Higuchi 
correlation coefficient values were 0.979, 0.985, 
0.992, 0.912, 0.990 and 0.990, respectively. 
 
DISCUSSION 
 
Gastroretentive floating microparticles have been 
investigated for improving the drug release of the 
drugs such as DTH which are well absorbed from 
upper GIT. Being the drug showing absorption 
window phenomenon, DTH is the most suitable 
candidate for developing the floating drug 
delivery systems. In the present study, 
gastroretentive floating microparticles of DTH 
were prepared using a simple and reproducible 
method. 
  
Scanning electron microscopy confirmed the 
hollow nature of microspheres with pores on the 
surface of floating microspheres, which might 
have imparted floating properties to the prepared 
floating microspheres [16,17]. Density was less 
than that of the gastrointestinal fluid, causing the 
microparticles to float over the gastric fluid. The 
presence of porous surface, internal voids and 
low densities of the prepared microspheres 
contributed to good buoyancy [17]. The average 
particle size of microspheres was found to be 
increasing with the increase in concentration of 
the polymer [21,22]. Drug to polymer ratio 
influenced almost all the physicochemical 
properties of the microspheres [23]. The % drug 
loading was found to be increasing with drug to 
polymer ratio in the present study.  
 
Drug release showed an inverse relation with 
concentration of polymer [24,25]. The linearity of 
the plot of cumulative percent of drug release 
versus time confirmed the zero order kinetics 
being followed by the formulations. The linearity 
of Higuchi plots indicated that the drug release 
from the microspheres followed the matrix 
diffusion process [22,26]. The prepared floating 
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microparticles are expected to reside for longer 
period of time in the upper gastric region and 
thereby leading to better bioavailability. 
 
CONCLUSION 
 
Findings from the present study show that the 
prepared microspheres exhibited good flow, 
floating and drug release properties. In this 
regard, microsphere formulations of cellulose 
acetate are superior to those prepared with 
Eudragit RS100. Thus, gastroretentive 
microspheres provide a potential alternative 
delivery system for the delivery of diltiazem in the 
treatment of cardiac disease. 
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